Related Experiment Videos
Morphine-induced immunomodulation is not related to serum morphine concentrations
H U Bryant1, B C Yoburn, C E Inturrisi
1Department of Medical Neuroscience, Walter Reed Army Institute of Research, Washington, DC 20307.
European Journal of Pharmacology
|April 27, 1988
Summary
Morphine pellets caused spleen and thymus atrophy in mice, suppressing immune cell responses. These effects persisted despite stable morphine blood levels, indicating direct drug impact on immunity.
Area of Science:
- Immunology
- Pharmacology
- Toxicology
Background:
- Opioids, including morphine, are known to affect the immune system.
- Understanding the specific immunomodulatory effects of sustained morphine exposure is crucial for clinical applications.
Purpose of the Study:
- To investigate the impact of sustained morphine administration via pellets on immune organs and lymphocyte function in mice.
- To correlate observed immunomodulatory effects with circulating morphine levels over time.
Main Methods:
- Mice were administered morphine via subcutaneous pellets.
- Spleen and thymus atrophy were assessed.
- Mitogen-induced lymphocyte proliferation (concanavalin A) was measured at 48 and 120 hours.
- Morphine blood levels were quantified.
Main Results:
- Morphine pellets induced significant atrophy of the spleen and thymus.
- Marked suppression of concanavalin A-induced blastogenesis was observed at 48 hours, with mild stimulation at 120 hours.
- Circulating morphine levels remained relatively stable and did not correlate with the dynamic changes in immunomodulatory effects.
- Enclosing the morphine pellet in nylon mesh did not alter blood levels or immunomodulatory outcomes.
Conclusions:
- Sustained morphine administration causes significant immune organ atrophy and alters lymphocyte proliferation.
- The immunomodulatory effects of morphine are not solely dependent on circulating drug concentrations.
- Morphine directly impacts immune function, independent of delivery method modifications.